SeaStar Medical Holding (ICU) Notes Payables (2020 - 2026)
SeaStar Medical Holding's (ICU) quarterly Notes Payables came in at $331000.0 in Q1 2026, down 8.82% YoY from $363000.0 in Q1 2025, and down 36.95% on a QoQ basis from $525000.0 in Q4 2025.
SeaStar Medical Holding (ICU) Notes Payables (2020 - 2026) Analysis & Trends
SeaStar Medical Holding (ICU) has 6 years of Notes Payables data on file, last reported at $331000.0 in Q1 2026.
- Quarterly Notes Payables fell 8.82% year-over-year to $331000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $331000.0 (down 8.82% YoY) and the FY2025 annual result came in at $525000.0, down 8.54% from the prior year.
- Notes Payables retreated to $331000.0 in Q1 2026, from $525000.0 in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $5.9 million in Q2 2023 to a low of $331000.0 in Q1 2026.
- A 5-year average of $1.3 million and a median of $545000.0 in 2023 frame the typical range for Notes Payables.
- Annual changes were most pronounced in 2024 — Notes Payables sank 55.98% — and 2025, when it climbed 1.68%.
- Tracing ICU's Notes Payables over 5 years: stood at $1.2 million in 2022, then slumped by 52.04% to $565000.0 in 2023, then advanced by 1.59% to $574000.0 in 2024, then retreated by 8.54% to $525000.0 in 2025, then slumped by 36.95% to $331000.0 in 2026.
- The last three Notes Payables figures came in at $331000.0 (Q1 2026), $525000.0 (Q4 2025), and $363000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | SeaStar Medical Holding | 13.68 Mn | 6.68 Mn | 561,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 134,000.00 |
| Mar 31, 2026 | 331,000.00 |
| Dec 31, 2025 | 525,000.00 |
| Mar 31, 2025 | 363,000.00 |
| Dec 31, 2024 | 574,000.00 |
| Jun 30, 2024 | 2.60 Mn |
| Mar 31, 2024 | 357,000.00 |
| Dec 31, 2023 | 565,000.00 |
| Jun 30, 2023 | 5.91 Mn |
| Mar 31, 2023 | 493,000.00 |
| Dec 31, 2022 | 1.18 Mn |
| Dec 31, 2020 | 126,413.00 |